Harold Pollack to Opioid-Related Disorders
This is a "connection" page, showing publications Harold Pollack has written about Opioid-Related Disorders.
Connection Strength
5.677
-
Support for evidence-informed opioid policies and interventions: The role of racial attitudes, political affiliation, and opioid stigma. Prev Med. 2022 05; 158:107034.
Score: 0.690
-
Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol. J Subst Abuse Treat. 2021 09; 128:108348.
Score: 0.642
-
Opioid Use by Pregnant and Parenting Women: Let's Not Repeat the Mistakes of 25 Years Ago. Milbank Q. 2019 09; 97(3):649-653.
Score: 0.574
-
Person-first language and addiction: A means to an end, not an end in itself. Prev Med. 2019 07; 124:115-116.
Score: 0.565
-
Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017. J Subst Abuse Treat. 2019 01; 96:18-22.
Score: 0.544
-
Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017 Feb 16; 376(7):605-607.
Score: 0.485
-
So Prescription Opioid Disorders are a $78.5 Billion Problem. Med Care. 2016 10; 54(10):899-900.
Score: 0.472
-
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings. PLoS One. 2022; 17(10):e0276066.
Score: 0.180
-
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey. Soc Sci Med. 2022 07; 305:115034.
Score: 0.174
-
Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults. Subst Use Misuse. 2021; 56(12):1752-1764.
Score: 0.165
-
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020 11 02; 3(11):e2023677.
Score: 0.157
-
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Score: 0.139
-
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. JAMA Netw Open. 2018 09 07; 1(5):e182943.
Score: 0.135
-
State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatr Serv. 2018 04 01; 69(4):448-455.
Score: 0.128
-
Non-buprenorphine opioid utilization among patients using buprenorphine. Addiction. 2017 Jun; 112(6):1045-1053.
Score: 0.121
-
Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health Aff (Millwood). 2016 12 01; 35(12):2289-2296.
Score: 0.119
-
Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels. J Subst Abuse Treat. 2014 10; 47(4):245-50.
Score: 0.101
-
Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev. 2014 Feb; 71(1):43-60.
Score: 0.096
-
HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.094
-
Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. J Urban Health. 2007 Mar; 84(2):292-306.
Score: 0.061
-
Changes in State Technical Assistance Priorities and Block Grant Funds for Addiction After ACA Implementation. Am J Public Health. 2019 06; 109(6):885-891.
Score: 0.035